Abstract
IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Current Neuropharmacology
Title: Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists
Volume: 9 Issue: 1
Author(s): S. F. Ali, E. S. Onaivi, P. R. Dodd, J. L. Cadet, S. Schenk, M. J. Kuhar and G. F. Koob
Affiliation:
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Abstract: IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Export Options
About this article
Cite this article as:
F. Ali S., S. Onaivi E., R. Dodd P., L. Cadet J., Schenk S., J. Kuhar M. and F. Koob G., Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017245
DOI https://dx.doi.org/10.2174/157015911795017245 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Molecular Basis of Memantine Action in Alzheimers Disease and Other Neurologic Disorders: Low-affinity, Uncompetitive Antagonism
Current Alzheimer Research iNOS: A Potential Therapeutic Target for Malignant Glioma
Current Molecular Medicine Brain Tumor Causes, Symptoms, Diagnosis and Radiotherapy Treatment
Current Medical Imaging Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
Current Drug Metabolism Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer’s Disease and Depression
Current Medicinal Chemistry Anderson-Fabry Disease in Children
Current Pharmaceutical Design Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued) Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Effects of Gene and Plasma Tau on Cognitive Impairment in Rural Chinese Population
Current Alzheimer Research Image Integration Procedures in Multisensory Medical Images: A Comprehensive Survey of the State-of-the-art Paradigms
Current Medical Imaging Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research
Current Drug Targets Adrenomedullin in Heart Failure: Molecular Mechanism and Therapeutic Implication
Current Hypertension Reviews Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury
Current Medicinal Chemistry Review: Therapeutic Targeting of HMGB1 in Stroke
Current Drug Delivery Dexamethasone Use During Pregnancy: Potential Adverse Effects on Embryonic Skeletogenesis
Current Pharmaceutical Design Pulmonary Arterial Hypertension: Need to Treat
Inflammation & Allergy - Drug Targets (Discontinued) Possible Exploitation of Non-Neuronal and Non-Chemical Synaptic Signalling Pathways in Epilepsy Therapy
Current Signal Transduction Therapy The Clinical Neuroscience of Post Stroke Depression
Current Neuropharmacology